Estimation of the size of the iatrogenic Creutzfeldt-Jakob disease outbreak associated with cadaveric dura mater grafts in Korea
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: This study estimated the overall incidence of iatrogenic Creutzfeldt-Jakob disease (iCJD) based on dura graft cases in Korea using a mathematical model. METHODS: We estimated the number of annual dura grafts performed between 1980 and 1995 by applying the proportion of dura grafts recorded by the Health Insurance Review Agency claim dataset in Korea to the number of nationwide neurosurgery cases. The distribution of the incubation period was assumed to fall under a Weibull distribution with density function or a log-logistic distribution with density function. RESULTS: The total number of neurosurgery procedures performed from 1980 to 1995 was estimated to be 263,945, and among those operations, 37% used dura graft products. Between the years of 1980 and 2020, our model predicted that the total number of iCJD cases would be between 14.9 and 33.2 (95% confidence interval [CI], 13.4 to 50.9). Notably, we estimated that the cumulative number of iCJD cases caused by dura grafts between 1980 and 2011 was approximately 13.3 to 27.3 (95% CI, 12.2 to 40.6). CONCLUSIONS: Based on our model, we postulate that the incidence of iCJD will sharply decline from 2012 to 2020. However, additional new cases are still expected, which necessitates a strong national surveillance system.
Abstract
OBJECTIVES: This study estimated the overall incidence of iatrogenic Creutzfeldt-Jakob disease (iCJD) based on dura graft cases in Korea using a mathematical model. METHODS: We estimated the number of annual dura grafts performed between 1980 and 1995 by applying the proportion of dura grafts recorded by the Health Insurance Review Agency claim dataset in Korea to the number of nationwide neurosurgery cases. The distribution of the incubation period was assumed to fall under a Weibull distribution with density function or a log-logistic distribution with density function. RESULTS: The total number of neurosurgery procedures performed from 1980 to 1995 was estimated to be 263,945, and among those operations, 37% used dura graft products. Between the years of 1980 and 2020, our model predicted that the total number of iCJD cases would be between 14.9 and 33.2 (95% confidence interval [CI], 13.4 to 50.9). Notably, we estimated that the cumulative number of iCJD cases caused by dura grafts between 1980 and 2011 was approximately 13.3 to 27.3 (95% CI, 12.2 to 40.6). CONCLUSIONS: Based on our model, we postulate that the incidence of iCJD will sharply decline from 2012 to 2020. However, additional new cases are still expected, which necessitates a strong national surveillance system.
참고문헌 (28)
- Prusiner SB, "Prions", Proc Natl Acad Sci U S A, 95, pp.13363~13383 (1998)
- "Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation, Geneva, Switzerland, 9-11 February 1998"[URL]
- 김상윤, "사람에서 발생하는 프리온 질환들", 대한의사협회지, 51(12), pp.1125~1138 (2008), 대한의사협회
- Masters CL, "Creutzfeldt-Jakob disease : patterns of worldwide occurrence and the significance of familial and sporadic clustering", Ann Neurol, 5, pp.177~188 (1979)
- Wang J, "Contribution of intravestibular sensory conflict to motion sickness and dizziness in migraine disorders", J Neurophysiol, 116, pp.1586~1591 (2016)
- Duffy P, "Letter : possible person-to-person transmission of Creutzfeldt-Jakob disease", N Engl J Med, 290, pp.692~693 (1974)
- Will RG, "Acquired prion disease: iatrogenic CJD, variant CJD, kuru", Br Med Bull, 66, pp.255~265 (2003)
- Brown P, "Iatrogenic Creutzfeldt-Jakob disease, final assessment", Emerg Infect Dis, 18, pp.901~907 (2012)
- Rappaport EB, "Iatrogenic Creutzfeldt-Jakob disease", Neurology, 37, pp.1520~1522 (1987)
- Food and Drug Administration (FDA), "FDA safety alert: possibly contaminated dura mater transplant material", US Department of Health and Human Services, Public Health Service, 1~15 (1987)
- 김혜림, "Dura Mater Graft-Associated Creutzfeldt-Jakob Disease: The First Case in Korea", Journal of Korean Medical Science, 26(11), pp.1515~1517 (2011), 대한의학회
- Triendl R, "CJD link prompts ban on brain tissue use", Nature, 387, pp.5~ (1997)
- Tanaka S, "Size of Creutzfeldt-Jakob disease epidemic associated with cadaveric dura transplantation", Neuroepidemiology, 34, pp.232~237 (2010)
- Lui KJ, "A model-based estimate of the mean incubation period for AIDS in homosexual men", Science, 240, pp.1333~1335 (1988)
- Kaplan ME, "HIV in adolescents", Clin Perinatol, 21, pp.75~84 (1994)
- Analysis of survival data, "Cox DR", 32~45 (1984)
- Gross AJ, "Survival distributions: reliability applications in the biomedical sciences", pp.112~113 (1975), John Wiley
- Hamada C, "Projection of Creutzfeldt-Jakob disease frequency based on cadaveric dura transplantation in Japan", Neuroepidemiology, 22, pp.57~64 (2003)
- Nagatsu T, "Molecular mechanisms of neurotransmission", Rinsho Shinkeigaku, 40, pp.1185~1188 (2000)
- "Diagnostic criteria"[URL]
- Hoshi K, "Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan", Neurology, 55, pp.718~721 (2000)
- Centers for Disease Control and Prevention, "Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1978-2008", MMWR Morb Mortal Wkly Rep, 57, pp.1152~1154 (2008)
- Brooke FJ, "Lyodura use and the risk of iatrogenic Creutzfeldt-Jakob disease in Australia", Med J Aust, 180, pp.177~181 (2004)
- Brandel JP, "The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide", Transfus Clin Biol, 20, pp.395~397 (2013)
- Brown P, "Iatrogenic Creutzfeldt-Jakob disease : the waning of an era", Neurology, 67, pp.389~393 (2006)
- Hamaguchi T, "Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan", wJ Neurol Neurosurg Psychiatry, 84, pp.1171~1175 (2013)
- Tateishi J, "Creutzfeldt-Jakob disease transmitted through cadaveric dura transplantation", J Clin Exp Med, 181, pp.992~993 (1997)
- Nakamura Y, "Relative risk of Creutzfeldt-Jakob disease with cadaveric dura transplantation in Japan", Neurology, 53, pp.218~220 (1999)